ENSC CIK: 1716947

Ensysce Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.24
FY22:
−17.9
FY23:
−10.8
FY24:
−7.50
FY25:
−7.81
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
0.00
FY23:
–
FY24:
–
FY25:
−0.12
Change from FY21 to FY25
millions USD
FY21:
20.3
FY22:
8.77
FY23:
8.76
FY24:
9.88
FY25:
8.74
millions USD
FY21:
12.1
FY22:
−9.12
FY23:
−2.02
FY24:
2.38
FY25:
0.81
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−7.93

All amounts in millions USD Data source:SEC EDGAR